Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Chihara

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Infection and Immunity|December 1, 1992
Interleukin-8 is a major neutrophil chemotactic factor derived from cultured human gingival fibroblasts stimulated with interleukin-1 beta or tumor necrosis factor alphaS Takashiba, M Takigawa, K Takahashi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 1, 1991
[Intestinal T-cell lymphoma (so-called malignant histiocytosis of the intestine) complicated by multiple perforations]S Sadamura, T Chihara, K Shibata, et al.
Journal of Medicinal Chemistry|July 9, 1993
Orally active, nonpeptide vasopressin V1 antagonists. A novel series of 1-(1-substituted 4-piperidyl)-3,4-dihdyro-2(1H)-quinolinoneH Ogawa, Y Yamamura, H Miyamoto, et al.
Cancer|August 15, 1986
Clinical evaluation of schizophyllan combined with irradiation in patients with cervical cancer. A randomized controlled studyK Okamura, M Suzuki, T Chihara, et al.
Nihon Gan Chiryo Gakkai Shi|October 20, 1983
[Therapeutic effect of peplomycin in cervical cancer, with special reference to pathohistological studies]K Noda, T Sugawa, S Kurihara, et al.
Biotherapy (Dordrecht, Netherlands)|January 1, 1989
Clinical evaluation of sizofiran combined with irradiation in patients with cervical cancer. A randomized controlled study; a five-year survival rateK Okamura, M Suzuki, T Chihara, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1986
[Radiation-induced secondary cancer in patients with uterine carcinoma]T Arai, K Fukuhisa, E Takeda, et al.
Journal of Periodontology|May 1, 1995
Clinical and laboratory studies on a patient with early onset periodontitis and her family members. A case reportK Takahashi, M Takigawa, H Hara, et al.
British Journal of Pharmacology|April 1, 1992
Characterization of a novel aquaretic agent, OPC-31260, as an orally effective, nonpeptide vasopressin V2 receptor antagonistY Yamamura, H Ogawa, H Yamashita, et al.
Oral Diseases|February 5, 2015
Comparing immunocompetent and immunodeficient mice as animal models for bone tissue engineeringY Zhang, X Li, T Chihara, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Infection and Immunity|December 1, 1992
Interleukin-8 is a major neutrophil chemotactic factor derived from cultured human gingival fibroblasts stimulated with interleukin-1 beta or tumor necrosis factor alphaS Takashiba, M Takigawa, K Takahashi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 1, 1991
[Intestinal T-cell lymphoma (so-called malignant histiocytosis of the intestine) complicated by multiple perforations]S Sadamura, T Chihara, K Shibata, et al.
Journal of Medicinal Chemistry|July 9, 1993
Orally active, nonpeptide vasopressin V1 antagonists. A novel series of 1-(1-substituted 4-piperidyl)-3,4-dihdyro-2(1H)-quinolinoneH Ogawa, Y Yamamura, H Miyamoto, et al.
Cancer|August 15, 1986
Clinical evaluation of schizophyllan combined with irradiation in patients with cervical cancer. A randomized controlled studyK Okamura, M Suzuki, T Chihara, et al.
Nihon Gan Chiryo Gakkai Shi|October 20, 1983
[Therapeutic effect of peplomycin in cervical cancer, with special reference to pathohistological studies]K Noda, T Sugawa, S Kurihara, et al.
Biotherapy (Dordrecht, Netherlands)|January 1, 1989
Clinical evaluation of sizofiran combined with irradiation in patients with cervical cancer. A randomized controlled study; a five-year survival rateK Okamura, M Suzuki, T Chihara, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1986
[Radiation-induced secondary cancer in patients with uterine carcinoma]T Arai, K Fukuhisa, E Takeda, et al.
Journal of Periodontology|May 1, 1995
Clinical and laboratory studies on a patient with early onset periodontitis and her family members. A case reportK Takahashi, M Takigawa, H Hara, et al.
British Journal of Pharmacology|April 1, 1992
Characterization of a novel aquaretic agent, OPC-31260, as an orally effective, nonpeptide vasopressin V2 receptor antagonistY Yamamura, H Ogawa, H Yamashita, et al.
Oral Diseases|February 5, 2015
Comparing immunocompetent and immunodeficient mice as animal models for bone tissue engineeringY Zhang, X Li, T Chihara, et al.
Pageof 7